End-of-Life Care for Patients with Mental Illness and Personality Disorders

Morgan, Betty D.

doi:10.1093/med/9780195391343.003.0041

Cited by 1 publication

(8 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Literature review C5 D2, D3 Meyer et al 38 Survey, N ¼ 17 C6 Miovic and Block 15 Literature review A1 C3, C6 D2 Moini and Levenson 24 Case study, N ¼ 1 B 2 D 4 Morgan 33 Literature review C1, C2, C3, C6 D2, D3 Muego 26 Media article, N ¼ 1 B 3 C 1 Myhill 29 Editorial C1, C2 Ng et al 31 Retrospective cohort study, N ¼ 191…”

Section: D1 D3 Mccasland 37mentioning

confidence: 99%

“…31,32 Morgan addressed the need for grief and bereavement support for long-term care home staff. 33 Pharmacology. Of the 32 articles, 9 offer best practices for pharmacology with the theme of coherent treatment for the patient's illness and the psychiatric disorder.…”

Section: Theme 3: Best Practicesmentioning

confidence: 99%

“…17,23,30 Furthermore, research demonstrated that individuals diagnosed with schizophrenia, most specifically those diagnosed with cancer, were less likely to obtain prescriptions to relieve pain, leading to a lower quality of care. 13,33 Family and team collaboration. Of the 32 articles, 5 discussed best practices for family team collaborations.…”

Section: Theme 3: Best Practicesmentioning

confidence: 99%

“…Collaborative work between the SDM and physicians can shape the best course of care for patients, even though the SDM will have the final decision. 22,33,35 Morgan describes how the privacy legislation may create conflict in sharing treatment information with family members who are not the SDM for a patient. 33 Support groups can also offer a realistic and beneficial option for bereaved family members.…”

Section: Theme 3: Best Practicesmentioning

confidence: 99%

“…22,33,35 Morgan describes how the privacy legislation may create conflict in sharing treatment information with family members who are not the SDM for a patient. 33 Support groups can also offer a realistic and beneficial option for bereaved family members. Miovic and Block focused on advanced terminal cancer, reporting that oncologists can work to bridge the gap in care, support, and communication for families.…”

Section: Theme 3: Best Practicesmentioning

confidence: 99%

See 4 more Smart Citations

On the Margins of Death: A Scoping Review on Palliative Care and Schizophrenia

et al. 2018

View full text Add to dashboard Cite

Schizophrenia is a serious chronic mental illness that results in marginalization and stigma for sufferers. It is the seventh leading cause for disability worldwide. The symptoms of the illness, including hallucinations, delusions, and extremely disordered thinking and behavior, may also introduce barriers to accessing treatment, education, housing, and employment. Little is known about endof-life care for individuals with schizophrenia. To address this gap, a scoping review was conducted to enhance understanding of hospice and palliative care for patients with schizophrenia. From this scoping review, 342 unique titles and abstracts were identified through a search of 20 databases, including 11 social science databases, 6 medical databases, and 3 gray literature databases. A total of 32 articles met the inclusion criteria and the following 4 themes were identified: 1. Stigma affecting quality of care and access to care; 2. Issues related to consent and capacity for the patient's end-of-life care decisions and to appoint substitute decision makers; 3. Best practices for psychosocial interventions, pharmacology, family and health-care collaborations, goals of care, setting, and smoking; and 4. Barriers to care, including setting, communication, provider education, and access to care. The review suggests the importance of mandatory interdisciplinary training practices and policy standards outlining cooperative communication across health-care providers. It highlights gaps in evidence-based research on psychosocial interventions and collaborative frameworks to enable the provision of quality end-of-life care for individuals with schizophrenia.

show abstract